Remarkable progress in HIV science has brought us a groundbreaking long-acting injectable drug offering six months of protection, a potential game-changer in the fight against the epidemic. However, decades of hard-won gains are under threat as political and social challenges loom, reports the International Aids Society.
Remarkable progress in HIV science has brought us a groundbreaking long-acting injectable drug offering six months of protection, a potential game-changer in the fight against the epidemic. However, decades of hard-won gains are under threat as political and social challenges loom, reports the of losing access to life-saving treatment due to the suspension of aid funding by the United States .
President Cyril Ramaphosa has expressed concern at the potential impact of the decision by the United States government to suspend some of its funding for HIV and Tuberculosis … The Joint United Nations Program on HIV/AIDS warns that the"pause of U.S. foreign assistance" to Ethiopia's national HIV response will be"particularly severe" for over…
News Politics Economy Trade Business Sports Current Events Travel Health And Medicine HIV-Aids And Stds Aid And Assistance External Relations United States Canada And Africa
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
US Aid Freeze Raises Concerns for Zimbabwe's HIV ResponseZimbabweans living with HIV and NGOs reliant on US funding express anxiety over the 90-day freeze on foreign development aid. The freeze could impede Zimbabwe's progress in meeting WHO targets for HIV, including expanding antiretroviral therapy access, reducing AIDS-related deaths, and increasing HIV testing.
Read more »
Pepfar Funding Review in South Africa: Uncertainty Looms Over HIV ProgramsThe US President's Emergency Plan for AIDS Relief (Pepfar) funding is facing a review, potentially impacting crucial HIV and Aids programs in South Africa. Health Minister Dr Aaron Motsoaledi confirmed the review, raising concerns about the future of the program and the 15,154 healthcare workers it supports.
Read more »
‘Unreliable partner’: South Africa’s HIV clinics scramble over US aid freezeSouth African HIV/AIDS healthcare providers have been scrambling for survival since US President Donald Trump issued a freeze on foreign aid.
Read more »
US funding freeze on HIV-Aids partially lifted for SAThe US waiver on HIV funding provides temporary relief for SA’s health services, but future support remains uncertain.
Read more »
US Funding Halt Cripples South Africa's HIV and TB FightA sudden halt in funding from the United States Agency for International Development (USAID) has sent shockwaves through South Africa's healthcare system, particularly in the fight against HIV and TB. This funding pause, under the new US administration, has effectively stopped critical programs that have been instrumental in providing treatment to over 4 million people in South Africa and preventing the spread of drug-resistant strains of these diseases. The lack of clarity and communication from US agencies has left partner organizations and patients in a state of uncertainty, fearing job losses, halted research, and interruptions in life-saving treatment.
Read more »
South Africa's Self-Reliance in HIV/AIDS Program Amidst Pepfar Funding ConcernsSouth African Health Minister Aaron Motsoaledi highlights the country's significant self-funding of its HIV/AIDS program, while addressing concerns about the potential withdrawal of US President's Emergency Plan for AIDS Relief (Pepfar) funding. The minister discusses the US government's review of Pepfar funding and restrictions on its use, as well as South Africa's efforts to establish local ARV production and address healthcare spending inequalities.
Read more »